John Garner

Comparison of the Absorption of Micronized (Daflon 500® mg) and Nonmicronized 14C‐diosmin Tablets After Oral Administration to Healthy Volunteers by Accelerator Mass Spectrometry and Liquid Scintillation Counting

R. Colin Garner, John Garner, S A Gregory et al. · Journal of Pharmaceutical Sciences · 2002 · 77 citations

Pharmaceutical Science, Accelerator Mass Spectrometry, Daflon 500® +13

Evaluation of Accelerator Mass Spectrometry in a Human Mass Balance and Pharmacokinetic Study–Experience with14C-labeled (R)-6-[Amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a Farnesyl Transferase Inhibitor

R. Colin Garner, Ivo Goris, Annouschka Laenen et al. · Drug Metabolism and Disposition · 2002 · 72 citations

A protocol for assay of poly(lactide- co -glycolide) in clinical products

John Garner, Sarah Skidmore, Haesun Park et al. · International Journal of Pharmaceutics · 2015 · 71 citations

Lactide- Co -Glycolide, Pharmaceutical Science, Medicine +9

A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts

R. Colin Garner, James Barker, C Flavell et al. · Journal of Pharmaceutical and Biomedical Analysis · 2000 · 64 citations

Engineering, Accelerator Ms, Validation Study +15

Characterization of branched poly(lactide-co-glycolide) polymers used in injectable, long-acting formulations

Justin Hadar, Sarah Skidmore, John Garner et al. · Journal of Controlled Release · 2019 · 54 citations

Biomanufacturing, Engineering, Polymer Science +7